We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Novel PET Tracer Identifies Majority of Bacterial Infections

By MedImaging International staff writers
Posted on 18 Oct 2017
Print article
Image: A 6\"-18F-fluoromaltotriose can detect viable E. coli bacteria one hour of implantation (Photo courtesy of Stanford University).
Image: A 6\"-18F-fluoromaltotriose can detect viable E. coli bacteria one hour of implantation (Photo courtesy of Stanford University).
A new positron emission tomography (PET) imaging agent offers a non-invasive method of detecting infection and monitoring antibiotic therapy.

Developed by researchers at Stanford University School of Medicine (CA, USA) and Thermo Fisher Scientific (Hanover Park, IL, USA), the new PET tracer is a derivative of maltose labeled with radioactive fluorine-18 (18F). The researchers conducted several studies in relevant bacterial strains in cultures and in living mice, and found that the tracer, dubbed 6"-18F-fluoromaltotriose, appears to be specific to bacterial infections, targeting a maltodextrin transporter expressed in both gram-positive and gram-negative strains of bacteria.

The researchers found that 6″-18F-fluoromaltotriose was also able to detect Pseudomonas aeruginosa in a clinically relevant mouse model of wound infection. In a rat model, the new agent was able to identify small bacterial foci in a heart valve. When the same rats were treated with an antibiotic, the PET signal from the cardiac tissue disappeared. According to the researchers, the properties of the tracer include sensitivity, specificity, and low background signal, which will facilitate its translation into humans. The study was published in the October 2017 issue of The Journal of Nuclear Medicine.

“We really lack tools in the clinic to be able to visualize bacterial infections. What we need is something that bacteria eat that your cells, so-called mammalian cells, do not,” said senior author Sanjiv Sam Gambhir, MD, PhD, chair of the radiology department at Stanford University School of Medicine. “As it turns out, there is such an agent, and that agent is maltose, which is taken up only by bacteria because they have a transporter, called a maltodextrine transporter, on their cell wall that is able to take up maltose and small derivatives of maltose.”

“The hope is that in the future when someone has a potential infection, this approach of injecting the patient with fluoromaltotriose and imaging them in a PET scanner will allow localization of the signal and, therefore, the bacteria,” concluded Dr. Gambhir. “And then, as one treats them, one can verify that the treatment is actually working; so that if it's not working, one can quickly change to a different treatment, for example, a different antibiotic.”

18F is a fluorine radioisotope that decays by positron emission 97% of the time, and electron capture 3% of the time; both modes of decay yield stable oxygen-18 (18O). 18F is an important radioisotope as a result of both its short half-life and the emission of positrons when decaying. It is primarily synthesized into fluorodeoxyglucose (FDG) for use in PET scans for cancer detection.

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Needle Guide
Ultra-Pro II
New
PACS Workstation
CHILI Web Viewer
New
Ultrasound Software
UltraExtend NX

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.